Active, Not Recruiting
Brigatinib and Bevacizumab for the Treatment of ALK-Rearranged Locally Advanced, Metastatic, or Recurrent NSCLC
NCT04227028
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +17 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- University of Colorado Cancer Center Aurora, Colorado, United States
- Northwestern University Chicago, Illinois, United States
- Rush University Medical Center Chicago, Illinois, United States